Glucagon-Like Peptide 1 Protects Pancreatic β-Cells From Death by Increasing Autophagic Flux and Restoring Lysosomal Function

Studies in animal models of type 2 diabetes have shown that glucagon-like peptide 1 (GLP-1) receptor agonists prevent β-cell loss. Whether GLP-1 mediates β-cell survival via the key lysosomal-mediated process of autophagy is unknown. In this study, we report that treatment of INS-1E β-cells and primary islets with glucolipotoxicity (0.5 mmol/L palmitate and 25 mmol/L glucose) increases LC3 II, a marker of autophagy. Further analysis indicates a blockage in autophagic flux associated with lysosomal dysfunction. Accumulation of defective lysosomes leads to lysosomal membrane permeabilization and release of cathepsin D, which contributes to cell death. Our data further demonstrated defects in autophagic flux and lysosomal staining in human samples of type 2 diabetes. Cotreatment with the GLP-1 receptor agonist exendin-4 reversed the lysosomal dysfunction, relieving the impairment in autophagic flux and further stimulated autophagy. Small interfering RNA knockdown showed the restoration of autophagic flux is also essential for the protective effects of exendin-4. Collectively, our data highlight lysosomal dysfunction as a critical mediator of β-cell loss and shows that exendin-4 improves cell survival via restoration of lysosomal function and autophagic flux. Modulation of autophagy/lysosomal homeostasis may thus define a novel therapeutic strategy for type 2 diabetes, with the GLP-1 signaling pathway as a potential focus.

[1]  P. Sun,et al.  Exendin-4 Enhances Motor Function Recovery via Promotion of Autophagy and Inhibition of Neuronal Apoptosis After Spinal Cord Injury in Rats , 2016, Molecular Neurobiology.

[2]  Chul-woo Yang,et al.  Effect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus , 2016, Scientific Reports.

[3]  A. Ballabio,et al.  TFEB at a glance , 2016, Journal of Cell Science.

[4]  Limei Liu,et al.  Dipeptidyl peptidase-4 inhibitor MK-626 restores insulin secretion through enhancing autophagy in high fat diet-induced mice. , 2016, Biochemical and biophysical research communications.

[5]  J. Mast,et al.  Heterozygous inactivation of plasma membrane Ca2+-ATPase in mice increases glucose-induced insulin release and beta cell proliferation, mass and viability , 2015, Diabetologia.

[6]  J. Debnath,et al.  Autophagy at the crossroads of catabolism and anabolism , 2015, Nature Reviews Molecular Cell Biology.

[7]  Rui-Hong Chen,et al.  Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy* , 2015, The Journal of Biological Chemistry.

[8]  D. Zou,et al.  Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E−/− mice by activating autophagy , 2015, Molecular medicine reports.

[9]  E. Feldman,et al.  The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain , 2015, Molecular Neurobiology.

[10]  D. Sabatini,et al.  Nutrient-sensing mechanisms and pathways , 2015, Nature.

[11]  N. Sarvetnick,et al.  Inhibition of Autophagic Turnover in β-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death* , 2014, The Journal of Biological Chemistry.

[12]  M. McCarthy,et al.  RNA Sequencing Identifies Dysregulation of the Human Pancreatic Islet Transcriptome by the Saturated Fatty Acid Palmitate , 2014, Diabetes.

[13]  M. Netea,et al.  Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes , 2014, Diabetologia.

[14]  Ju-ming Lu,et al.  Palmitate induces autophagy in pancreatic β-cells via endoplasmic reticulum stress and its downstream JNK pathway. , 2013, International journal of molecular medicine.

[15]  H. Marshall,et al.  Expression of Mesenchymal and α-Cell Phenotypic Markers in Islet β-Cells in Recently Diagnosed Diabetes , 2013, Diabetes Care.

[16]  S. Yagihashi,et al.  Exendin-4 improves β-cell function in autophagy-deficient β-cells. , 2013, Endocrinology.

[17]  M. Jäättelä,et al.  Lysosomal cell death at a glance , 2013, Journal of Cell Science.

[18]  B. Tirosh,et al.  Stimulation of Autophagy Improves Endoplasmic Reticulum Stress–Induced Diabetes , 2013, Diabetes.

[19]  M. Côrte-Real,et al.  Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release , 2013, Cell Death and Disease.

[20]  M. Bugliani,et al.  Palmitate Activates Autophagy in INS-1E β-Cells and in Isolated Rat and Human Pancreatic Islets , 2012, PloS one.

[21]  Z. Al-Oanzi,et al.  Elevated Glucose Represses Liver Glucokinase and Induces Its Regulatory Protein to Safeguard Hepatic Phosphate Homeostasis , 2011, Diabetes.

[22]  F. Anania,et al.  GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy , 2011, PloS one.

[23]  O. Shirihai,et al.  Fatty Acids Suppress Autophagic Turnover in β-Cells* , 2011, The Journal of Biological Chemistry.

[24]  K. Riabowol,et al.  REAP: A two minute cell fractionation method , 2010, BMC Research Notes.

[25]  A. Attie,et al.  Gastrointestinal hormones and the regulation of β‐cell mass , 2010, Annals of the New York Academy of Sciences.

[26]  R. Kawamori,et al.  Free fatty acids stimulate autophagy in pancreatic β-cells via JNK pathway. , 2010, Biochemical and biophysical research communications.

[27]  G. Fontés,et al.  Glucolipotoxicity of the pancreatic beta cell. , 2010, Biochimica et biophysica acta.

[28]  L. Olson,et al.  Activation of autophagy through modulation of 5'-AMP-activated protein kinase protects pancreatic beta-cells from high glucose. , 2010, The Biochemical journal.

[29]  P. Marchetti,et al.  Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB , 2009, Diabetes.

[30]  Valerio Embrione,et al.  A Gene Network Regulating Lysosomal Biogenesis and Function , 2009, Science.

[31]  U. Boggi,et al.  Autophagy in human type 2 diabetes pancreatic beta cells , 2009, Diabetologia.

[32]  J. Debnath,et al.  PLIC proteins or ubiquilins regulate autophagy‐dependent cell survival during nutrient starvation , 2009, EMBO reports.

[33]  Masaaki Komatsu,et al.  Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. , 2008, Cell metabolism.

[34]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[35]  Guido Kroemer,et al.  Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.

[36]  T. Noda,et al.  Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3 , 2007, Autophagy.

[37]  B. Yusta,et al.  GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress , 2006 .

[38]  K. Kirkegaard,et al.  Subversion of Cellular Autophagosomal Machinery by RNA Viruses , 2005, PLoS biology.

[39]  J. Holst,et al.  On the Physiology of GIP and GLP-1 , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[40]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[41]  L. Agius,et al.  Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells. , 2000, Diabetes.

[42]  S. Efendić,et al.  Dysfunction of the Islet Lysosomal System Conveys Impairment of Glucose-Induced Insulin Release in the Diabetic GK Rat. , 1999, Endocrinology.

[43]  Ji‐Hyun Lee,et al.  Protective role of autophagy in palmitate-induced INS-1 beta-cell death. , 2009, Endocrinology.

[44]  B. Yusta,et al.  GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. , 2006, Cell metabolism.

[45]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.